Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Elizabeth Lee, MD, is a medical oncologist in the gynecologic oncology program at Dana-Farber Cancer Institute. She also serves as the gynecologic oncology program's liaison to the Center for Cancer Therapeutics Innovation. Dr. Lee received her undergraduate degree from Yale University and completed her Doctor of Medicine at the University of Pittsburgh School of Medicine. She completed an internal medicine residency at the Johns Hopkins Hospital and hematology/oncology fellowship at the Dana-Farber Cancer Institute and Massachusetts General Hospital. Dr. Lee is engaged in clinical research efforts testing novel molecularly-targeted therapies in the treatment of ovarian and endometrial cancers and in translational studies evaluating mechanisms of treatment resistance.
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions